Skip to content

Fiber-enriched Buckwheat Pasta and Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease

Fiber-enriched Buckwheat Pasta Reduces Daily Glucose Variability in Patients With Type 1 Diabetes and Celiac Disease: an Acute Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03380988
Enrollment
10
Registered
2017-12-21
Start date
2015-11-30
Completion date
2017-02-28
Last updated
2017-12-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Celiac Disease, Type 2 Diabetes Mellitus

Brief summary

The intervention was preceded by a 1-week run-in period during which participants underwent continuous glucose monitoring (CGM) and filled in a 7-day dietary record to optimize basal infusion rate and insulin-to-glycemic load ratio. The study had a randomized crossover design with each subject studied on 2 occasions at least 1 week apart. Participants were assigned to consume, in random order, two test meals with the same amount of carbohydrates (50g): a meal containing fiber-enriched buckwheat pasta (FBP) or corn pasta (CP), used as control. Over the experimental period, participants underwent CGM, wearing their sensors 7 days/week.

Interventions

OTHERAcute test meal with fiber-enriched buckwheat pasta

Pasta with tomato sauce (100g tomato sauce, 5g extra-virgin olive oil)

OTHERAcute test meal with corn pasta

Pasta with tomato sauce (100g tomato sauce, 5g extra-virgin olive oil)

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age: 20-50 years * Documented history of celiac disease and type 1 diabetes.

Exclusion criteria

* Pregnancy/breast feeding * Serious microvascular and macrovascular diabetes complications * Any other chronic or acute disease apart from diabetes seriously affecting health status

Design outcomes

Primary

MeasureTime frameDescription
Postprandial glucose response6 hoursIncremental area under the curve

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026